The Ministry of Finance issued Notification No. 05/2024-Integrated Tax (Rate) on 8th October 2024, amending the Integrated Goods and Services Tax (IGST) rates. The amendments are made under the powers conferred by section 5 of the IGST Act, 2017, following recommendations from the GST Council. In Schedule I (5% rate), three medicines—Trastuzumab Deruxtecan, Osimertinib, and Durvalumab—have been added. Schedule II (12% rate) now includes extruded or expanded savoury or salted products, excluding unfried or uncooked snack pellets. In Schedule III (18% rate), the description of snack pellets is updated to include both unfried and uncooked products as well as extruded or expanded savoury or salted products. Schedule III also revises the tax rate on certain seats, excluding aircraft and motor vehicle seats. Schedule IV (28% rate) introduces seats specifically designed for motor vehicles. These amendments will come into effect from 10th October 2024. This notification builds on earlier updates made to the principal notification No. 1/2017-Integrated Tax (Rate), initially issued on 28th June 2017, with the last amendment in July 2024.
MINISTRY OF FINANCE
(Department of Revenue)
Notification No. 05/2024- Integrated Tax (Rate) | Dated: 8th October, 2024
G.S.R. 613(E).— In exercise of the powers conferred by sub-section (1) of section 5 and Integrated Goods and Services Tax Act, 2017 (13 of 2017), the Central Government, on the recommendations of the Council, hereby makes the following further amendments in the notification of the Government of India, Ministry of Finance (Department of Revenue), notification No. 1/2017- Integrated Tax (Rate), dated the 28th June, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Subsection (i), vide number G.S.R. 666(E), dated the 28th June, 2017, namely:-
In the said notification, –
(a)after Schedule I – 5% , in List 1, after item number 232 and the entries relating thereto, the following item numbers and entries shall be inserted, namely: –
“(233) Trastuzumab Deruxtecan
(234) Osimertinib
(235) Durvalumab”;
(b) in Schedule II – 12%, after S. No. 32B and the entries relating thereto, the following S. No. and entries shall be inserted, namely: –
| “32C | 1905 | Extruded or expanded products, savoury or salted (other than un-fried or un-cooked |
| 90 30 | snack pellets, by whatever name called, manufactured through process of extrusion)”; |
(c) in Schedule III – 18%, –
(i) against S. No. 16, in column (3), for the words “un-fried or un-cooked snack pellets, by whatever name called, manufactured through process of extrusion”, the words “ un-fried or un-cooked snack pellets, by whatever name called, manufactured through process of extrusion, extruded or expanded products, savoury or salted” shall be substituted;
(ii) for S. No. 435A and the entries relating thereto, the following S. No. and entries shall be substituted, namely: –
| “435A | 9401 [other than 9401 10 00 or 9401 20 00] | Seats (other than those of heading 9402), whether or not convertible into beds and parts thereof other than seats of a kind used in aircraft or seats of a kind used for motor vehicles”; |
(d) in Schedule IV – 28%, after S. No. 210 and the entries relating thereto, the following S. No. and entries shall be inserted, namely: –
| “210A | 9401 20 00 | Seats of a kind used for motor vehicles”. |
2. This notification shall come into force on the 10th day of October, 2024.
[F. No. CBIC-190354/149/2024-TO(TRU-II)]
AMREETA TITUS, Dy. Secy.
Note: – The principal notification No. 1/2017- Integrated Tax (Rate), dated the 28th June, 2017, was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R. 666(E), dated the 28th June, 2017, and was last amended vide notification No. 2/2024 – Integrated Tax (Rate), dated the 12th July, 2024, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R. 397(E), dated the 12th July, 2024.
